Reports for EMTRICITABINE

Ingredient

EMTRICITABINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-EMTRICITABINE/TENOFOVIR 200MG 300MG TABLET Resolved 2020-11-06 2021-01-07 128004
TEVA-EMTRICITABINE/TENOFOVIR 300MG 200MG TABLET Resolved 2022-04-21 2023-06-21 159201
AURO-EMTRICITABINE-TENOFOVIR 200MG 300MG TABLET Actual shortage 2024-03-27 2024-03-28 223603
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2018-04-27 2019-06-19 47356
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2019-06-25 2019-07-03 87463
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 200MG 300MG TABLET Avoided shortage 2020-04-29 2020-07-09 113424
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2017-09-27 2017-10-02 23663
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2018-03-05 2018-03-20 41868
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-04-04 2019-05-21 80530
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-07-12 2019-08-17 89158

Showing 1 to 10 of 28

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1